Khosla Ventures VI, L.P.
CIK: 0001734961
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FTH
Faeth Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Khosla Ventures VI, L.P.
Khosla Ventures VI, L.P. (SEC CIK 0001734961) files insider reports with the SEC as 10% Owner of Faeth Therapeutics, Inc. (FTH).
Signal8 holds 1 ownership filing by Khosla Ventures VI, L.P., a Form 3, filed on Jul 28, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Khosla Ventures VI, L.P.'s filings is in MENLO PARK, CA.
Other insiders filing for Faeth Therapeutics, Inc. (FTH)
- Schayowitz Adam, Director
- Vousden Karen H, Director
- Craver Josiah, PAO
- Parikh Anand Kiran, President and CEO
- STEPHENSON BRIAN C, Chief Financial Officer
- Ramasastry Saira, Director